TG Therapeutics | TGTX - 流动资产



金融业
股票价格
USD
资产
USD 1.64B
现金及等价物
USD 612.25M
销售成本
USD 41.19M
流动资产
USD 1.15B
流动负债
USD 268.49M
债务
USD 754.44M
EBIT
USD 21.67M
EBITDA
USD 26.9M
员工
338
EPS每股收益
USD 0.05
股本和储备
USD 604.08M
销售毛利
USD 199.14M
债务利息支出
USD 16.57M
贷款资金
USD 745.39M
市值
USD 8.22B
净收入
USD 7.78M
营业费用
USD 218.66M
营业利润
USD 21.67M
普通股股本
USD 153.08M
PE价格收益
19.64
税前利润
USD 10.23M
销售收入
USD 240.34M
销售和管理费用
USD 62.33M
股票
USD 147.97M
贸易债权人
USD 213.69M
应收帐款人
USD 401.57M


流动资产 更改 日
AbbVie USD 33.67B 140M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 34.96B 3.49B 2026-06
Ardelyx USD 381.87M 447K 2026-03
Arrowhead Research USD 1.67B 168.34M 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Biogen USD 7.31B 1.88B 2026-06
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Curis USD 16.61M 9.7M 2026-03
Gilead Sciences USD 12.53B 6.11B 2026-06
J&J USD 59.77B 601M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Novartis USD 27.35B 744M 2026-06
Novavax USD 771.1M 79.72M 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06
Verastem USD 202.9M 20.51M 2026-03
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06